Drug shortage
Ramipril Capsule · Pfizer Inc.
FDA drug shortage · To Be Discontinued · updated Jan 30, 2025
Key facts
| Generic name | Ramipril Capsule |
|---|---|
| Company | Pfizer Inc. |
| Presentation | Altace, Capsule, 10 mg (NDC 61570-120-01) |
| Dosage form | Capsule |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 61570-120-01 |
| First posted | Jan 30, 2025 |
| Last updated | Jan 30, 2025 |
| Discontinued | Jan 30, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: